Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Thiazoles »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Thiamine Pyrophosphate < Thiazoles < Thiazolidinediones  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000113 (1999) W J Weiner [États-Unis]The initial treatment of Parkinson's disease should begin with levodopa.
000114 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000217 (2000) C W Olanow [États-Unis] ; A H Schapira ; T. RothWaking up to sleep episodes in Parkinson's disease.
000295 (2000) S J Frucht ; P E Greene ; S. FahnSleep episodes in Parkinson's disease: a wake-up call.
000301 (2000) R A Hauser [États-Unis] ; L. Gauger ; W M Anderson ; T A ZesiewiczPramipexole-induced somnolence and episodes of daytime sleep.
000407 (2000) R A Hauser [États-Unis] ; M N Wahba ; T A Zesiewicz ; W. Mcdowell AndersonModafinil treatment of pramipexole-associated somnolence.
000568 (2001) J L Montastruc ; O. RascolModafinil and pramipexole-associated somnolence.
000874 (2002) DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
000998 (2003) Prithiva Navan [Royaume-Uni] ; Leslie J. Findley ; Jim A R. Jeffs ; Ronald K B. Pearce ; Peter G. BainDouble-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
000B11 (2003) P K MorrishREAL and CALM: what have we learned?
000B97 (2003) Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa ; Sadako Kuno ; Mitsutoshi Yamamoto ; Kazuko Hasegawa ; Hideki Origasa ; Hisayuki KowaRandomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
000C30 (2003) Prithiva Navan [Royaume-Uni] ; Leslie J. Findley ; Jim A R. Jeffs ; Ronald K B. Pearce ; Peter G. BainRandomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor.
000C83 (2004) Connie Marras [Canada] ; Anthony Lang ; Murray Krahn ; George Tomlinson ; Gary NaglieQuality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
000F16 (2004) Andreas Meisel ; Christine Winter ; Rolf Zschenderlein ; Guy ArnoldTourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride.
000F47 (2004) Marco Mucchiut [Italie] ; Enrico Belgrado ; Daniela Cutuli ; Angelo Antonini ; Paolo BergonziPramipexole-treated Parkinson's disease during pregnancy.
000F67 (2004) Katherine Grosset [Royaume-Uni] ; Fiona Needleman ; Graeme Macphee ; Donald GrossetSwitching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
000F82 (2004) Yvonne Körner [Allemagne] ; Charlotte Meindorfner ; Jens Carsten Möller ; Karin Stiasny-Kolster ; Doris Haja ; Werner Cassel ; Wolfgang Hermann Oertel ; Hans-Peter KrügerPredictors of sudden onset of sleep in Parkinson's disease.
001001 (2004) William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova ; Abdulah Sherzai ; Antonella Favit ; M M Mouradian ; Thomas N. ChaseEffect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.
001164 (2005) J Carsten Möller [Allemagne] ; Wolfgang H. Oertel ; Jürgen Köster ; Gianni Pezzoli ; Leandro ProvincialiLong-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
001217 (2005) Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol ; Cristina SampaioEvidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
001277 (2005) Pershia Samadi [Canada] ; Laurent Grégoire ; Arash Rassoulpour ; Paolo Guidetti ; Emanuela Izzo ; Robert Schwarcz ; Paul J. BédardEffect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Thiazoles" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Thiazoles" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Thiazoles
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024